English Polski
Vol 15, No 5 (2020)
Original paper
Published online: 2020-12-30

open access

Page views 740
Article views/downloads 488
Get Citation

Connect on Social Media

Connect on Social Media

Carotid arterial stiffness in type 2 diabetic patients

Zbigniew Bociąga1, Joanna Jaroch1, Małgorzata Wilczyńska2, Ewa Kruszyńska1, Maria Łoboz-Rudnicka1, Barbara Rzyczkowska1, Izabella Uchmanowicz3, Krystyna Łoboz-Grudzień3
Folia Cardiologica 2020;15(5):333-342.

Abstract

Background: Functional carotid arterial changes expressed by arterial stiffness indices represent subclinical organ damage in subjects with type 2 diabetes mellitus (T2D). There are still controversies to what extent diabetes per se influences arterial stiffness and what is the contribution of other atherosclerotic risk factors in arterial stiffness pathophysiology. The aim of the study was to assess carotid arterial stiffness in patients with uncomplicated T2D. We examined the relationship of classical cardiovascular risk factors and haemoglobin A1 and arterial stiffness indices in diabetes. Methods: The study group consisted of 168 subjects: 84 subjects with T2D (34 M, 50 F, mean age 55,8±7,9) and 84 healthy patients (60 M, 24 F, mean age 54,3±7,0). From carotid arteries ultrasound - high-resolution echo-tracking (eT) arterial stiffness parameters were evaluated: β, Ep, AC, AI, PWV-β. Results: β, Ep, AI, PWV- β were higher in patients with T2D in the comparison with control group. In the group of T2D in stepwise multivariate analysis of arterial stiffness indices the following models were achieved with only significant variables β=1.8+0.096xPP+0.07xage; R2=0.166, Ep=16.7+1.852xPP; R2=0.286, AC=1.9–0.005xSBP–0.007xHR+0.14xsmoking cigarettes; R2=0.165, AI=18.0–0.80xBMI+0.40xage; R2=0.147. PWV-β=- 0.4+0.77xSBP–0.72xMAP–0.50xPP+0.03xHR; R2=0.235 Conclusions: T2D constitutes the strong independent determinant of arterial stiffness. In patients with T2D the independent determinants of arterial stiffness parameters were age, SBP, MBP, PP, HR, BMI and smoking cigarettes. Not only glycemic control but also a multifactorial anti-risk strategy might play an important role in the prevention of the development of vascular stiffness and subclinical target organ damage in diabetes

Article available in PDF format

View PDF Download PDF file

References

  1. Rydén L, Grant PJ, Anker SD. Authors/Task Force Members. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013; 34(39): 3035–3087.
  2. Blankenhorn DH, Kramsch DM. Reversal of atherosis and sclerosis. The two components of atherosclerosis. Circulation. 1989; 79(1): 1–7.
  3. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005; 25(5): 932–943.
  4. Zieman SJ, Kass DA. Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease. Drugs. 2004; 64(5): 459–470.
  5. Stehouwer CD, Ferreira I. Diabetes, lipids and other risk factors. In: Safar ME, O’Rourke MF. ed. Arterial stiffness in hypertension. Elsevier, London 2006: 427–456.
  6. Cruickshank K, Riste L, Anderson SG, et al. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002; 106(16): 2085–2090.
  7. Choi SW, Shin MH, Yun WJ, et al. Association between hemoglobin A1c, carotid atherosclerosis, arterial stiffness, and peripheral arterial disease in Korean type 2 diabetic patients. J Diabetes Complications. 2011; 25(1): 7–13.
  8. Chen Y, Huang Y, Li X, et al. Association of arterial stiffness with HbA1c in 1,000 type 2 diabetic patients with or without hypertension. Endocrine. 2009; 36(2): 262–267.
  9. Genuth S, Eastman R, Kahn R, et al. American Diabetes Association. Implications of the United kingdom prospective diabetes study. Diabetes Care. 2003; 26(Suppl 1): S28–S32.
  10. Devereux RB, Alonso D, Lutas E, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986; 57(6): 450–458.
  11. Pignoli P, Tremoli E, Poli A, et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986; 74(6): 1399–1406.
  12. Sugawara M, Niki K, Furuhata H, et al. Relationship between the pressure and diameter of the carotid artery in humans. Heart Vessels. 2000; 15(1): 49–51.
  13. Jaroch J, Rzyczkowska B, Bociąga Z, et al. The relationship of carotid arterial stiffness to left ventricular diastolic dysfunction in untreated hypertension. Kardiol Pol. 2012; 70(3): 223–231.
  14. Magda SL, Ciobanu AO, Florescu M, et al. Comparative reproducibility of the noninvasive ultrasound methods for the assessment of vascular function. Heart Vessels. 2013; 28(2): 143–150.
  15. Bowie A, Owens D, Collins P, et al. Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient? Atherosclerosis. 1993; 102(1): 63–67.
  16. Ceriello A, Quatraro A, Giugliano D. New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med. 1992; 9(3): 297–299.
  17. Vlachopoulos C, Terentes-Printzios D, Stefanadis C. Arterial stiffness and carotid intima-media thickness: together they stand. Hypertens Res. 2010; 33(4): 291–292.
  18. Palombo C, Malshi E, Morizzo C. Association between local carotid artery stiffness and aortic stiffness in subjects with cardiovascular risk factors. Eur J Echocardiogr. 2008; 9(Suppl): S65 (abstract).
  19. Laurent S, Cockcroft J, Van Bortel L, et al. European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006; 27(21): 2588–2605.
  20. Antonini-Canterin F, Carerj S, Di Bello V, et al. Research Group of the Italian Society of Cardiovascular Echography (SIEC). Arterial stiffness and ventricular stiffness: a couple of diseases or a coupling disease? A review from the cardiologist's point of view. Eur J Echocardiogr. 2009; 10(1): 36–43.
  21. Avgeropoulou C, Illmann A, Schumm-Draeger PM, et al. Assessment of arterio-ventricular coupling by tissue Doppler and wave intensity in type 2 diabetes. The British Journal of Diabetes & Vascular Disease. 2016; 6(6): 271–278.
  22. Avolio AP, Deng FQ, Li WQ, et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation. 1985; 71(2): 202–210.
  23. Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension. 2009; 54(6): 1328–1336.
  24. Sa Cunha R, Pannier B, Benetos A, et al. Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects. J Hypertens. 1997; 15(12 Pt 1): 1423–1430.
  25. Tanokuchi S, Okada S, Ota Z. Factors related to aortic pulse-wave velocity in patients with non-insulin-dependent diabetes mellitus. J Int Med Res. 1995; 23(6): 423–430.
  26. Takahara M, Katakami N, Osonoi T, et al. Different impacts of cardiovascular risk factors on arterial stiffness versus arterial wall thickness in Japanese patients with type 2 diabetes mellitus. J Atheroscler Thromb. 2015; 22(9): 971–980.
  27. Jacob MP. Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother. 2003; 57(5-6): 195–202.
  28. Greenwald SE. Ageing of the conduit arteries. J Pathol. 2007; 211(2): 157–172.
  29. McEniery CM, Hall IR, Qasem A, et al. ACCT Investigators. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005; 46(9): 1753–1760.
  30. Taniwaki H, Kawagishi T, Emoto M, et al. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care. 1999; 22(11): 1851–1857.
  31. Kumeda Y, Inaba M, Shoji S, et al. Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes. Clin Endocrinol (Oxf). 2008; 69(4): 556–561.
  32. Benetos A, Laurent S, Hoeks AP, et al. Arterial alterations with aging and high blood pressure. A noninvasive study of carotid and femoral arteries. Arterioscler Thromb. 1993; 13(1): 90–97.
  33. McCance DR, Ritchie CM, Kennedy L. Is HbA1 measurement superfluous in NIDDM? Diabetes Care. 1988; 11(6): 512–514.
  34. Larsen JR, Brekke M, Bergengen L, et al. Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes. Diabetologia. 2005; 48(4): 776–779.
  35. Standl E, Schnell O, Ceriello A. Postprandial hyperglycemia and glycemic variability: should we care? Diabetes Care. 2011; 34 Suppl 2: S120–S127.
  36. Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia. 2001; 44(12): 2107–2114.
  37. Lefèbvre PJ, Scheen AJ. The postprandial state and risk of cardiovascular disease. Diabetic Medicine. 1998; 15(S4): S63–S68, doi: 10.1002/(sici)1096-9136(1998120)15:4+3.3.co;2-z.
  38. Muramatsu J, Kobayashi A, Hasegawa N, et al. Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin. Atherosclerosis. 1997; 130(1-2): 179–182.
  39. Raison J, Rudnichi A, Safar ME. Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study. J Hum Hypertens. 2002; 16(10): 705–710.
  40. van Popele NM, Mattace-Raso FUS, Vliegenthart R, et al. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke. 2001; 32(2): 454–460.
  41. Zureik M, Temmar M, Adamopoulos C, et al. Carotid plaques, but not common carotid intima-media thickness, are independently associated with aortic stiffness. J Hypertens. 2002; 20(1): 85–93.
  42. Zureik M, Bureau JM, Temmar M, et al. Echogenic carotid plaques are associated with aortic arterial stiffness in subjects with subclinical carotid atherosclerosis. Hypertension. 2003; 41(3): 519–527.
  43. Borow KM, Newburger JW. Noninvasive estimation of central aortic pressure using the oscillometric method for analyzing systemic artery pulsatile blood flow: comparative study of indirect systolic, diastolic, and mean brachial artery pressure with simultaneous direct ascending aortic pressure measurements. Am Heart J. 1982; 103(5): 879–886.